
Nucleic Acid research reagents:
o TransIT® Transfection Reagents
§ reagents of unique lipid and polymer formulations that achieve superior delivery efficiency of pDNA and siRNA with minimal cytotoxic effects
o Label IT® Labeling Reagents
§ employ proprietary chemistry to covalently attach labeling molecules to DNA and RNA.
§ faster and more robust than traditional multi-step enzymatic labeling, and can be used for intracellular tracking, chromosome analysis, and microarray labeling
Therapeutic products:
o MyoDys® Muscular Dystrophy Therapy
§ Stage: Phase I/II in preparation
§ treat disease by inserting a gene encoding active dystrophin into affected muscles to delay or prevent loss of muscle function
o Peripheral Ischemia Therapy
§ Stage: Research
§ treatment is based upon delivery of a gene encoding an angiogenic factor to the affected limb, which induces revascularization of the limb